A Safe & Effective Solution For All
Bring Proven Phototherapy Into Modern Dermatology Workflows
Dermatologists have relied on narrowband ultraviolet B (NB-UVB) phototherapy for decades to treat psoriasis, vitiligo, and cutaneous T-cell lymphoma (CTCL), where it remains a first-line therapy in the American Academy of Dermatology (AAD) guidelines. For atopic dermatitis (eczema), phototherapy is an important option when topical treatments are not enough.
Phothera helps make prescribing and managing phototherapy simple with tools designed to support both your practice and your patients.
NB-UVB delivers targeted therapeutic light under prescription guidance without the harmful UV exposure associated with tanning beds or uncontrolled sun exposure.
Why Dermatologists Choose Phototherapy with Phothera
- Reduce reliance on systemic medications: A medication-free treatment option for psoriasis, vitiligo, CTCL, and atopic dermatitis.
- Improved adherence with home phototherapy: Guided Mode devices include AAD protocols with built-in safety guardrails and demonstrated 3x higher adherence in the 783-patient LITE clinical trial.
- Simplify prescribing and workflow: Compatible with Epic and EMA to support prescribing and documentation.
- Expand patient access: Broad insurance coverage with $0 cost for eligible patients, helping remove financial barriers to treatment.
Phototherapy for Chronic Skin Conditions
Narrowband UVB phototherapy is a first-line treatment for psoriasis, vitiligo, and CTCL, and an important treatment option for atopic dermatitis when topical therapies are not sufficient.
Phothera makes this clinically proven therapy accessible both in the clinic and at home through prescription phototherapy systems designed to support physician-directed care.
PSORIASIS
- Reduces inflammation and visible plaque buildup
- Effective as a standalone or combination therapy
- No systemic medications required for many patients
- Supported by AAD treatment guidelines
ATOPIC DERMATITIS
- Calms immune-driven inflammation and persistent itch
- Helps reduce the frequency and severity of flares
- A clinically supported step-up when topical therapies are not enough
VITILIGO
- Stimulates natural repigmentation over time
- Phototherapy combined with topical therapy is up to 2X more effective than topical treatment alone
- Physician-directed treatment with clinical oversight maintained at home
CTCL
- Targeted phototherapy treatment used in early-stage CTCL management
- Longstanding therapy used in dermatology and oncology settings
- Physician-directed treatment with clinical oversight maintained at home
Different conditions. One clinically trusted treatment approach.
Home Phototherapy, the Way It Should Be Prescribed
Phothera delivers phototherapy solutions designed to support both at-home treatment for patients and in-office care for dermatology practices. Built on decades of Narrowband UVB clinical use, our systems help expand access to treatment while simplifying prescribing and improving adherence.
At-Home Phototherapy
- Prescribed by your dermatologist and designed for safe home treatment
- Guided Mode with on-device app and AAD treatment protocols built in
- 3x higher adherence compared with standard home therapy (LITE Study, n=783)1
- Broad insurance coverage with $0 cost for eligible patients*
- EMR-compatible prescribing with Epic® and EMA®
*$0 patient cost applies to eligible insured patients. Not all patients will qualify.
In-Office Phototherapy
- Covered by most major insurance providers
- Clinical phototherapy devices designed for dermatology practices
- Expand treatment offerings within your practice
- Recommended in national dermatology treatment guidelines
The same proven Narrowband UVB therapy. Delivered where it works best for your patient.
Phototherapy & lifestyle changes have helped me regain control of my life.
– Karen
Your Path Forward
For Providers: Start prescribing home phototherapy for your patients.
For Patients: Learn whether prescription home phototherapy may be right for your condition.
For Health Plans: Support clinically proven care while helping manage long-term treatment costs.
References:
- Gelfand JM, Armstrong AW, Lim HW, et al. JAMA Dermatol. 2024; doi:10.1001/jamadermatol.2024.3897
EMA is a registered trademark of Modernizing Medicine, Inc. Epic is a registered trademark of Epic Systems Corporation.